- Home
- LENZ vs RGR Comparison
LENZ vs RGR Comparison
Compare LENZ & RGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LENZ
- RGR
- Stock Information
- Founded
- LENZ 2019
- RGR 1949
- Country
- LENZ United States
- RGR United States
- Employees
- LENZ N/A
- RGR N/A
- Industry
- LENZ Medicinal Chemicals and Botanical Products
- RGR Ordnance And Accessories
- Sector
- LENZ Health Care
- RGR Industrials
- Exchange
- LENZ Nasdaq
- RGR Nasdaq
- Market Cap
- LENZ 664.5M
- RGR 699.8M
- IPO Year
- LENZ 2021
- RGR N/A
- Fundamental
- Price
- LENZ $24.67
- RGR $41.09
- Analyst Decision
- LENZ Strong Buy
- RGR
- Analyst Count
- LENZ 6
- RGR 0
- Target Price
- LENZ $35.40
- RGR N/A
- AVG Volume (30 Days)
- LENZ 168.0K
- RGR 93.7K
- Earning Date
- LENZ 08-14-2024
- RGR 10-30-2024
- Dividend Yield
- LENZ N/A
- RGR 1.86%
- EPS Growth
- LENZ N/A
- RGR N/A
- EPS
- LENZ N/A
- RGR 1.86
- Revenue
- LENZ N/A
- RGR $519,091,000.00
- Revenue This Year
- LENZ N/A
- RGR $2.79
- Revenue Next Year
- LENZ N/A
- RGR $1.33
- P/E Ratio
- LENZ N/A
- RGR $22.00
- Revenue Growth
- LENZ N/A
- RGR N/A
- 52 Week Low
- LENZ $2.01
- RGR $40.21
- 52 Week High
- LENZ $31.00
- RGR $55.58
- Technical
- Relative Strength Index (RSI)
- LENZ 50.64
- RGR 44.76
- Support Level
- LENZ $25.13
- RGR $40.77
- Resistance Level
- LENZ $31.00
- RGR $42.59
- Average True Range (ATR)
- LENZ 2.09
- RGR 0.57
- MACD
- LENZ 0.15
- RGR 0.04
- Stochastic Oscillator
- LENZ 26.31
- RGR 27.81
About LENZ LENZ Therapeutics Inc. Common Stock
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About RGR Sturm Ruger & Company Inc.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The Company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.